Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Evidence HRT could reduce bowel cancer risk

February 2, 2009 Research and Development, Sales and Marketing HRT

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …
News

The Pfizer-Wyeth merger

February 2, 2009 Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales

Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …
Feature

AstraZeneca to cut more jobs as sales stagnate

January 30, 2009 Sales and Marketing AZ, restructure

AstraZeneca's revenues will see virtually no growth in 2009, and the company has extended its cost cutting programme. Chief executive …
News

Crucell linked with new takeover suitors

January 29, 2009 Sales and Marketing Crucell, MA

Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …
News

Independent study into NICE’s methods

January 29, 2009 Sales and Marketing NICE, hc

NICE has asked an eminent academic and NHS reformer to conduct an independent study of its approach to appraising new …
News

RoActemra approved in Europe

January 29, 2009 Sales and Marketing RoActemra, Roche

The European Commission has approved Roche's RoActemra as a treatment for rheumatoid arthritis. Schering-Plough's Remicade, Wyeth's Enbrel and Abbott's Humira …
News

Plavix sales help BMS into profit

January 29, 2009 Sales and Marketing BMS, Plavix

Strong fourth quarter sales of its blockbuster blood thinner Plavix have helped Bristol-Myers Squibb back into the black. Net earnings …
News

Electronic decision support and the future of medicine

January 29, 2009 Sales and Marketing clinical decision support, technology

Feature

Novartis launches Extavia in Europe

January 28, 2009 Sales and Marketing Extavia, MS

Novartis has launched its new multiple sclerosis injection Extavia in Europe and hopes this will lay the groundwork for an …
News

Who owns the brand?

January 27, 2009 Sales and Marketing branding, marketing

For all of us in brand marketing, it is worth remembering that creating and nurturing a brand can be like …
Feature

Pfizer unveils $68 billion takeover of Wyeth

January 26, 2009 Sales and Marketing MA, Pfizer

Pfizer has unveiled a deal to acquire Wyeth for $68 billion, creating a new giant in pharmaceuticals, biotech, vaccines, consumer …
News

Green light for kidney cancer drugs in Wales

January 26, 2009 Sales and Marketing NHS, par, rcc

Kidney cancer patients in Wales are to gain access to the four new drugs that are still denied on the …
News

Pfizer to make merger bid for Wyeth

January 26, 2009 Sales and Marketing MA, Pfizer

Pfizer looks set to make a multi-billion dollar takeover of fellow US pharma company Wyeth.The world's largest pharma company, Pfizer …
News

GSK hopeful of NICE approval for Tyverb

January 26, 2009 Sales and Marketing Cancer, GSK, breast cancer

NICE could be poised to reverse its rejection of GSK's breast cancer treatment Tyverb, the pharma company has said.NICE rejected …
News

Merck Serono’s multiple sclerosis drug on track for filing

January 23, 2009 Research and Development, Sales and Marketing MS, Merck Serono

Cladribine, a new oral treatment for multiple sclerosis is on track for a mid-2009 filing after the release of encouraging …
News
The Gateway to Local Adoption Series

Latest content

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026